Spero

Spero Therapeutics is a clinical-stage biopharmaceutical company advancing innovative medicines for immune-mediated diseases, beginning with SP001, a third-generation anti-CD40L antibody in development for IgG4-related disease

sperotherapeutics.com

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceutical

Model

01Company Overview

Spero Therapeutics is a clinical-stage biopharmaceutical company advancing innovative medicines for immune-mediated diseases, beginning with SP001, a third-generation anti-CD40L antibody in development for IgG4-related disease.

02Backed By1 investor

SOSR One→

03Similar Companies